eValuate: Turning Cost Data into Lab Performance

Every lab runs tests. But few know what they cost — and fewer still what they’re worth. That’s where eValuate changes everything.

Built for laboratories, not spreadsheets, eValuate is LTS’s proprietary cost intelligence tool designed to reveal what traditional reporting can’t.

By unifying finance, LIS, HR, and operational data, it calculates true cost-per-test, uncovers margin risk, and enables decisions grounded in real numbers — not assumptions.

From strategic pricing to analyser optimisation, eValuate helps labs track what drives performance and where value leaks out.

It’s not just a tool. It’s a mindset shift — empowering finance and operations to speak the same language, act faster, and grow smarter.

When you can see the numbers, you can shape the outcome.

Explore eValuate — and see what your lab is really running on.

eValuate: Turning Cost Data into Lab Performance

How a proprietary cost intelligence tool is helping labs unlock margin, operational clarity, and strategic control — one test at a time.

Introduction

Modern laboratories are under pressure — to do more, with less, at higher standards. But while clinical innovation has surged, cost visibility hasn’t kept pace. Most labs still rely on traditional P&L reporting that masks critical inefficiencies and profit leakage at the test level.

LTS built eValuate to change that. Designed specifically for the complexity of lab environments, eValuate delivers repeatable, activity-based cost-per-test calculations — turning raw operational data into actionable financial insights. It helps labs move beyond surface metrics, revealing what’s driving margin, what’s holding performance back, and where decisions can unlock value.

The Challenge:
Why Traditional Reporting Isn’t Enough

Most labs generate reams of financial data — but much of it arrives too late, too broad, or too disconnected from operations to drive real decisions. Quarterly reports may show cost trends, but they can’t explain why reagent spend is spiking or which analysers are dragging down margins.

Without site-, department-, or test-level visibility, labs are left guessing. Budgeting becomes defensive, pricing is inconsistent, and cost-saving efforts miss the mark. What labs need is granularity — and a system built to deliver it.

The Solution:
Introducing eValuate

eValuate is LTS’s proprietary cost intelligence tool — a platform designed to answer one question: What does it really cost to run your lab?

Using data from your finance, LIS, HR, and equipment systems, eValuate calculates true cost, revenue, and profit per test — from organisation level all the way down to individual tests and analysers. It applies a laboratory-optimised version of activity-based costing (ABC), balancing detail with repeatability, and replacing assumptions with structured, data-driven logic.

From Model to Action:
How It Works in Practice

Labs typically deploy eValuate in sprints — starting with high-level insights and progressively unlocking deeper operational layers:

Sprint 1 (Site Level): Map cost and revenue across labs. Identify outliers. Benchmark performance.

Sprint 2 (Department Level): Tag reagent consumption. Analyse staff cost allocation. Highlight high-cost disciplines.

Sprint 3 (Test/Analyzer Level): Track analyser utilisation. Identify unprofitable tests. Re-price or reassign workloads.

This layered approach gives labs fast wins while building internal alignment — with finance, operations, and clinical leads finally working from the same dataset.

The Impact:
What Labs Can Expect

A recent 4-site lab network using eValuate delivered the following results in under 12 months:

R9.4 million in operating cost savings

5-point increase in EBITDA margin

12% improvement in analyser utilisation

15% floor space freed by retiring inefficient equipment

R3.1 million in cash freed through tighter reagent inventory management

And perhaps most powerfully — department heads began using cost-per-test data for budgeting, pricing, and day-to-day decisions.

Why It Matters:
Bridging Finance and Operations

eValuate does more than calculate costs. It closes the gap between two worlds:

Finance sees where margin is leaking and where investment pays off.

Operations sees how behaviour, equipment, and process decisions impact profitability.

Together, they align around test-level performance — enabling more accurate budgets, smarter pricing, targeted cost control, and better resource planning.

It also builds a data-driven culture. When every department sees its cost drivers, every team member becomes an owner of performance.

Looking Ahead:
From Insight to Advantage

In a changing healthcare landscape, cost intelligence is no longer a back-office function —
it’s a competitive advantage. eValuate gives laboratories the financial visibility they need to navigate change, invest wisely, and lead with confidence.

It’s not just about saving money. It’s about building
a system that’s fit for the future — scalable, transparent, and strategically aligned from the
test bench to the boardroom.

You can’t optimise what you can’t see. With eValuate, laboratories don’t just understand their costs — they turn them into performance.